✦ LIBER ✦

The therapy (combination of conezym Q10, Vitamin B6. With iron) for Alzheimer's disease and senile dementia of the Alzheimer type

Book ID: 122953404
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 128 KB
Volume: 11
Category: Article
ISSN: 0197-4580
DOI: 10.1016/0197-4580(90)90941-R

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapy with a combination of iron, vita

Therapy with a combination of iron, vitamin B6 and coenzyme Q10 in the long term for sporadic Alzheimer's disease

✍ Arib-Mezdad, A.; Lamara-Mahamed, A. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 186 KB

291 Combined therapy with iron, vitamin

291 Combined therapy with iron, vitamin B6, and coenzyme Q10 in 27 patients with Alzheimer disease

✍ M. Imagawa 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Comparative assessment of regional cereb

Comparative assessment of regional cerebral blood flow through combination therapy of iron with B4, C0Q10 for 2years in Alzheimer's disease and senile dementia of Alzheimer type

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 178 KB

Autoantibodies to β-Amyloid and Neurotra

Autoantibodies to β-Amyloid and Neurotransmitters in Patients with Alzheimer's Disease and Senile Dementia of the Alzheimer Type

✍ M.A. Myagkova; S.I. Gavrilova; N.N. Lermontova; Ya.B. Kalyn; N.D. Selezneva; G.A 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 387 KB

Clinical trials with the cholinergic dru

Clinical trials with the cholinergic drug RS 86 in Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT)

✍ Albert Wettstein; René Spiegel 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 216 KB

The muscarinic agonist RS 86 was administered to patients with Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT) in a series of controlled clinical trials. Daily doses were up to 3.0 mg orally for a maximum duration of 18 weeks. RS 86 produced typical peripheral cholinergic e

Somatostatin-like immunoreactivity and n

Somatostatin-like immunoreactivity and neurotransmitter metabolites in the cerebrospinal fluid of patients with senile dementia of Alzheimer type and Parkinson's disease

✍ M. Strittmatter; D. Strubel; C. Reuner; F. Kuntzmann; H. Cramer 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 63 KB